|
|
HIV Update 2003 (2) - FebruaryPublished by: Datamonitor Published: Apr. 28, 2003 - 14 Pages Table of Contents EXECUTIVE SUMMARY ANALYSIS OF KEY DEVELOPMENTS IN FEBRUARY COMPANY HEADLINES RESEARCH AND DEVELOPMENT HEADLINES DISEASE SPECIFIC HEADLINES EMERGING MARKETS HEADLINES APPENDIX AbstractIntroductionProvides an account of all the key market events that took place during February 2003. Key events include new product launches, clinical trial data and conference findings. Key events are analyzed in the HIV market during February. Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors. Future of HIV therapy lies in simplification of drug regimens. Scope Key events are analyzed in the HIV market during February Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors Report Highlights The announcement of Fuzeon's price point Further clinical trial data from Boehringer Ingelheim's tipranavir Reasons to Purchase Stay informed of all of the important market led events taking place in the HIV market Gain insight into the likely market impact of the events that took place in February 2003 in the HIV market Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||